HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Α-aryl-N-alkyl nitrones, as potential agents for stroke treatment: synthesis, theoretical calculations, antioxidant, anti-inflammatory, neuroprotective, and brain-blood barrier permeability properties.

Abstract
We report the synthesis, theoretical calculations, the antioxidant, anti-inflammatory, and neuroprotective properties, and the ability to cross the blood-brain barrier (BBB) of (Z)-α-aryl and heteroaryl-N-alkyl nitrones as potential agents for stroke treatment. The majority of nitrones compete with DMSO for hydroxyl radicals, and most of them are potent lipoxygenase inhibitors. Cell viability-related (MTT assay) studies clearly showed that nitrones 1-3 and 10 give rise to significant neuroprotection. When compounds 1-11 were tested for necrotic cell death (LDH release test) nitrones 1-3, 6, 7, and 9 proved to be neuroprotective agents. In vitro evaluation of the BBB penetration of selected nitrones 1, 2, 10, and 11 using the PAMPA-BBB assay showed that all of them cross the BBB. Permeable quinoline nitrones 2 and 3 show potent combined antioxidant and neuroprotective properties and, therefore, can be considered as new lead compounds for further development in specific tests for potential stroke treatment.
AuthorsMourad Chioua, David Sucunza, Elena Soriano, Dimitra Hadjipavlou-Litina, Alberto Alcázar, Irene Ayuso, María Jesús Oset-Gasque, María Pilar González, Leticia Monjas, María Isabel Rodríguez-Franco, José Marco-Contelles, Abdelouahid Samadi
JournalJournal of medicinal chemistry (J Med Chem) Vol. 55 Issue 1 Pg. 153-68 (Jan 12 2012) ISSN: 1520-4804 [Electronic] United States
PMID22126405 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antioxidants
  • Free Radical Scavengers
  • Lipoxygenase Inhibitors
  • N-((2-chloro-6-methylquinolin-3-yl)methylene)-1-phenylmethanamine oxide
  • N-((2-chloro-6-methylquinolin-3-yl)methylene)-2-methylpropan-2-amine oxide
  • Neuroprotective Agents
  • Nitric Oxide Donors
  • Nitrogen Oxides
  • Oximes
  • Quinolines
  • nitrones
  • Superoxides
  • Hydroxyl Radical
Topics
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (chemical synthesis, chemistry, pharmacology)
  • Antioxidants (chemical synthesis, chemistry, pharmacology)
  • Blood-Brain Barrier (metabolism)
  • Cell Hypoxia
  • Cell Survival (drug effects)
  • Cells, Cultured
  • Cerebral Cortex (cytology)
  • Edema (drug therapy)
  • Female
  • Free Radical Scavengers (chemical synthesis, chemistry, pharmacology)
  • Hydroxyl Radical (metabolism)
  • Lipid Peroxidation (drug effects)
  • Lipoxygenase Inhibitors (chemical synthesis, chemistry, pharmacology)
  • Male
  • Necrosis
  • Neurons (cytology, drug effects)
  • Neuroprotective Agents (chemical synthesis, chemistry, pharmacology)
  • Nitric Oxide Donors (chemical synthesis, chemistry, pharmacology)
  • Nitrogen Oxides (chemical synthesis, chemistry, pharmacology)
  • Oximes (chemical synthesis, chemistry, pharmacology)
  • Permeability
  • Quinolines (chemical synthesis, chemistry, pharmacology)
  • Rats
  • Rats, Inbred F344
  • Rats, Sprague-Dawley
  • Stereoisomerism
  • Stroke (drug therapy)
  • Structure-Activity Relationship
  • Superoxides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: